These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17185177)

  • 1. Approach to the diagnosis of neuroendocrine lung neoplasms: variabilities and pitfalls.
    Hammar SP
    Semin Thorac Cardiovasc Surg; 2006; 18(3):183-90. PubMed ID: 17185177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Classification of broncho-pulmonary cancers (WHO 1999)].
    Brambilla E
    Rev Mal Respir; 2002 Sep; 19(4):455-66. PubMed ID: 12417862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinomas of the lung with neuroendocrine differentiation.
    Carter D; Yesner R
    Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas: comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas.
    Kakinuma H; Mikami T; Iwabuchi K; Yokoyama M; Hattori M; Ohno E; Kuramoto H; Jiang SX; Okayasu I
    Cancer; 2003 Aug; 99(4):247-54. PubMed ID: 12925987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
    Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stainability of lung cancer cells with Leu-7 and OKT-9 monoclonal antibodies.
    Sato Y; Watanabe S; Kodama T; Goto M; Shimosato Y
    Jpn J Clin Oncol; 1985 Sep; 15(3):537-44. PubMed ID: 2414490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine differentiation in non-small cell lung carcinomas.
    Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F
    In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine structures in normal and diseased human lung.
    Mosca L; Ceresoli A; Anzanello E; Mauri F; Mariscotti C; Timossi R; Barbareschi M; Mezzetti M
    Appl Pathol; 1986; 4(3):147-61. PubMed ID: 3036186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroendocrine tumors of the lung].
    Takei H; Asamura H
    Nihon Rinsho; 2004 May; 62(5):877-82. PubMed ID: 15148812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological implications of bronchial tumors.
    Warren WH; Memoli VA; Kittle CF; Jensik RJ; Faber LP; Gould VE
    J Thorac Cardiovasc Surg; 1984 Feb; 87(2):274-82. PubMed ID: 6319828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.
    Rossi G; Marchioni A; Milani M; Scotti R; Foroni M; Cesinaro A; Longo L; Migaldi M; Cavazza A
    Am J Clin Pathol; 2004 Dec; 122(6):884-93. PubMed ID: 15595193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of cytologic diagnosis of early lung cancer.
    Vazquez MF; Koizumi JH; Henschke CI; Yankelevitz DF
    Cancer; 2007 Aug; 111(4):252-8. PubMed ID: 17614298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumors in the lung--morphologic features and the challenge of integrating biomarker signatures into diagnostics.
    Vollmer E; Schultz H; Stellmacher F; Kähler D; Abdullah M; Galle J; Lang DS; Goldmann T
    Rom J Morphol Embryol; 2010; 51(4):607-14. PubMed ID: 21103615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potential.
    Yatabe Y; Osada H; Tatematsu Y; Mitsudomi T; Takahashi T
    Oncogene; 2002 Nov; 21(54):8310-9. PubMed ID: 12447694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features.
    Faggiano A; Sabourin JC; Ducreux M; Lumbroso J; Duvillard P; Leboulleux S; Dromain C; Colao A; Schlumberger M; Baudin E
    Cancer; 2007 Jul; 110(2):265-74. PubMed ID: 17569104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytologic, histologic and electron microscopic correlations in poorly differentiated primary lung carcinoma. A study of 43 cases.
    Mennemeyer R; Hammar SP; Bauermeister DE; Wheelis RF; Jones HW; Bartha M
    Acta Cytol; 1979; 23(4):297-302. PubMed ID: 231365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of neural-cadherin in pulmonary epithelial tumours.
    Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV
    Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytopathologic diagnosis of pulmonary neoplasms in sputum and bronchoscopic specimens.
    Erozan YS
    Semin Diagn Pathol; 1986 Aug; 3(3):188-95. PubMed ID: 3616222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of electron microscopy and immunohistochemistry in the diagnosis and understanding of lung neoplasms.
    Hammar S
    Clin Lab Med; 1987 Mar; 7(1):1-30. PubMed ID: 3030610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.